Today, Aignostics announced research results for Atlas 2, an updated version of its pathology foundation model. Built in collaboration with Mayo Clinic, LMU Munich and Charité – Universitätsmedizin ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced an ...
SAN FRANCISCO, Jan 13 () - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug ...
Alterity Therapeutics (ASX: ATH) is a late clinical-stage biotechnology company focused on developing treatments for serious ...
The FDA has granted fast track designation to a vectorized antibody that targets RNA-binding proteins characteristic of ...
Modella AI, a leader in artificial intelligence for life sciences, today announced that it has been acquired by AstraZeneca, expanding the companies' existing collaboration to advance the application ...
Flow Space on MSN
Cervical Cancer May Be Eliminated By 2030
The largest barriers to elimination are no longer scientific. The science and tech are finally here—women just need to catch ...
Across Europe and beyond, real-world deployments now span teleconsultation, telemonitoring, tele-expertise exchange, ...
TROPION-Lung17 will enroll approximately 400 patients across global sites. Participants are randomized 1:1 to receive either Dato-DXd (6.0 mg/kg intravenously every 3 weeks) or docetaxel (75 mg/m² ...
After a busy first day featuring headlines from a who's who of leading biopharma companies, the J.P. | The J.P. Morgan ...
Transverse colon samples from confirmed Alzheimer’s disease cases showed distinct gut microbiome and proteomic shifts, ...
These suits represent the next frontier: whether manufacturers of regulated cannabis products may be held liable for injuries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback